SCHEMBL55043

SCHEMBL55043

NC(=O)c1cc[c]cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28348727 0.91 L3MBTL1 (0.46)
SCHEMBL323980 0.85 CA2 (0.53)
Terephthalamide SCHEMBL7508927 0.82 PARP1 (0.67)
Benzamide SCHEMBL28225616 0.80 PARP1 (0.73)
SCHEMBL8727096 0.80 ROCK1 (0.46)
SCHEMBL9620387 0.79 PARP10 (0.41)
Terephthalamide SCHEMBL23774 0.78 PARP1 (0.71)
SCHEMBL28426696 0.78
SCHEMBL1535886 0.77 ALDH1A1 (0.50)
Terephthalamide SCHEMBL11512422 0.76 PARP1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4897 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024121013-A1 SULFONYL DERIVATIVES AS CCR6 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2024-06-13 WO claimed
US-20240116903-A1 TETRAHYDROQUINOLINE DERIVATIVE AND MEDICINAL USE THEREOF TORAY INDUSTRIES, INC. (JP) 2024-04-11 US claimed
CN-117732246-A g-C 3 N 4 Preparation method and application of nano-sheet/KANF composite nanofiltration membrane 浙江工业大学 2024-03-22 CN claimed
WO-2023249105-A1 THERAPEUTIC AGENT OR PREVENTIVE AGENT FOR DRUG-INDUCED MYOCARDIAL DISORDERS 東レ株式会社 2023-12-28 WO claimed
WO-2023249107-A1 THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR PERIPHERAL NERVE DISORDER 東レ株式会社 2023-12-28 WO claimed
WO-2023249106-A1 THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS 東レ株式会社 2023-12-28 WO claimed
WO-2023239846-A1 HETEROCYCLIC COMPOUNDS AS PI3KΑ INHIBITORS SYNNOVATION THERAPEUTICS, INC. (US) 2023-12-14 WO claimed
US-20230357255-A1 IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS INCYTE CORPORATION 2023-11-09 US claimed
EP-4269392-A1 TETRAHYDROQUINOLINE DERIVATIVE AND MEDICINAL USE THEREOF Toray Industries, Inc. (JP) 2023-11-01 EP claimed
US-20230339904-A1 ISOINDOLINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2023-10-26 US claimed
EP-0011048-B1 A PROCESS FOR THE MANUFACTURE OF SUBSTANTIALLY PURE 3-AMINO-4-ALKOXY-ACYLANILIDES FROM 2,4-DINITROCHLOROBENZENE Toms River Chemical Corporation (US) 1982-01-27 EP claimed
US-4297357-A ANTIULCER AGENTS; ANTISECRETORY AGENTS DAIICHI SEIYAKU CO., LTD. (JP) 1981-10-27 US claimed
US-4293306-A Process for the dyeing and printing of hydrophobic synthetic organic fiber materials with water-insoluble azo dyestuffs HOECHST AKTIENGESELLSCHAFT (DE) 1981-10-06 US claimed
US-4283556-A Process for the manufacture of substantially pure 3-amino-4-alkoxy-acylanilides from 2,4-dinitrochlorobenzene TOMS RIVER CHEMICAL CORPORATION (US) 1981-08-11 US claimed
EP-0031708-A2 Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor ICI PHARMA (FR) 1981-07-08 EP claimed
US-4247479-A REACTING THE OXIME HYDROCHLORIDE WITH THREE MOLES OF ACETIC ANHYDRIDE HOECHST AKTIENGESELLSCHAFT (DE) 1981-01-27 US claimed
US-4233445-A SYNERGISTIC WITH SULFA DRUGS AS BACTERICIDES AND ANTIPROTOZOA AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 1980-11-11 US claimed
EP-0011048-A1 A process for the manufacture of substantially pure 3-amino-4-alkoxy-acylanilides from 2,4-dinitrochlorobenzene Toms River Chemical Corporation (US) 1980-05-14 EP claimed
EP-0009608-A1 N-Phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them DAIICHI SEIYAKU CO., LTD. (JP) 1980-04-16 EP claimed
US-4013768-A VASODILATION, ANTIULCER, HYPOTENSIVE, DIURETIC, ANALGESIC, ANTIINFLAMMATORY DELALANDE S.A. (FR) 1977-03-22 US claimed